FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
marketwatch.com
23.09.2026 14:39
36 views
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Related stories
How you can prepare for 6% bond yields
marketwatch.com · 13.10
Bank of America fined $1.2bn over money laundering failures
ft.com · 13.10
Midterm voters haven’t seen this many housing proposals on the ballot in 20 years
marketwatch.com · 13.10
Saudi-led coalition strikes Houthi targets in Yemen capital
ft.com · 13.10
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties
marketwatch.com · 13.10
Russia arrests Japanese journalist on espionage charges
ft.com · 13.10